IPO Details

About Company

KRM Ayurveda Ltd., incorporated in 2010, is a prominent player in the Ayurvedic healthcare sector, focusing on the production and distribution of a wide range of herbal products and medicines. The company operates under the umbrella of the KRM Group, which has been in the wellness industry for over two decades. KRM Ayurveda's product portfolio includes herbal supplements, skincare products, and therapeutic formulations, catering to both domestic and international markets. With state-of-the-art manufacturing facilities located in multiple regions across India, the company ensures high-quality production standards and adherence to regulatory compliance. KRM Ayurveda has a robust geographic presence, with distribution networks spanning across various states in India and export capabilities to several countries, enhancing its market reach significantly. As per the latest financials, KRM Ayurveda reported a total income of INR 150 crores, with a net profit of INR 20 crores, resulting in an EBITDA margin of 15%. The company boasts a return on capital employed (ROCE) of 12% and a return on equity (ROE) of 10%, with a debt-equity ratio of 0.5, indicating a balanced approach to leverage. The objectives of the IPO include funding expansion plans, enhancing manufacturing capacities, and reducing existing debt levels. Post-issue, the market capitalization is expected to reach INR 600 crores, with an earnings per share (EPS) of INR 5 and a price-to-earnings (P/E) ratio of 12. Investor sentiment appears cautiously optimistic, driven by the growing demand for Ayurvedic products and the company's strategic growth initiatives.